The prevalence and associations of bronchial hyperresponsiveness were investigated in a general practice population. 
The prevalence of bronchial hyperresponsiveness was 23%. Bronchial hyperresponsiveness was not associated with age but was more prevalent in women than men (31%: 13%). It was also more common in those who had ever wheezed (39%) and in those who had had an attack of rhinitis in the preceding month (45%, p < 0-1), in atopic individuals (30%), and in smokers (32%), but it was not associated with cough or dyspnoea. There was a positive correlation between PC20FEV, and resting FEV, (r = 0 288) and a negative correlation between PC20FEV, and mean daily peak flow variability (r = -0 356). Stepwise binary logistic regression analysis showed significant independent effects on PC20FEV, for mean (0-4% phenol, 0-275% NaHCO3, 05% NaCI) initially followed by increasing doubling concentrations of methacholine, from 0-06 to 32 mg/ml for those with symptoms and from 0 25 mg/ml to 32 mg/ml for those without symptoms. The test was terminated when FEV, had fallen by 20% from the lowest of the three values obtained after the control inhalation, or when the highest concentration of methacholine had been administered. FEV, was plotted non-cumulatively against the log concentration of methacholine administered to obtain the PC20FEV, by interpolation.
Subjects were asked to record their peak flow twice daily (on rising and retiring) for 14 days, using a mini-Wright peak flow meters (Clement Clarke Ltd). Daily peak flow variability was calculated as the difference between the maximum and minimum peak flow values as a percentage of the maximum value.
Retrospective analysis of the general practice notes was carried out by a single observer (C J T) for the five year period June 1982 to June 1987 without knowledge of the subject's PC20 value. Notes were analysed systematically for the number of attendances with the following complaints: upper respiratory tracttonsillitis, sinusitis, hay fever or rhinitis, "upper respiratory tract infection"; lower respiratory tract-asthma, wheeze, cough, productive cough, or bronchitis.
SUBJECTS
The study was conducted in a four partner general practice in Kingston, Surrey, with a list size of approximately 8000 patients of whom approximately 6000 were aged between 18-75 years. The practice has a particular interest in asthma and atopy and keeps detailed notes. Initially three 1 in 12 systematic samples of all patients aged 18-75 were obtained from the practice age-sex register by taking every fourth card and allocating it systematically to one of three lists. By definition, the three lists were age and sex matched to within a year in age so that non-responders from the first 1 in 12 sample could be replaced by a substitute of the same sex and similar age. We anticipated a low response rate, particularly among young working men, and thus had to approach replacements to obtain a sample that represented the demography of the practice population.
Of the 473 patients selected initially, 47 had moved from the area at the time of the study and six were judged unsuitable to participate because they had carcinoma, severe psychiatric illness, or severe cardiovascular disease. Five with severe asthma requiring regular medication with inhaled or oral corticosteroids were excluded. Thus 415 people were written to and asked if they would be willing to take part in a study of "how the lungs work." It was emphasised in the letter that people who had no evidence of respiratory illness were required as much as people who had. Those who failed to reply to the first letter were sent two further letters.
Of the 240 people (58%) who replied, 179
(43%/-) agreed to take part in the study, though 21 of these failed to attend. Thus 158 (38%) of the original sample were seen. A further 619 letters were sent to people in the replacement groups, of whom 208 took part, giving an overall sample size of 366 and an overall response rate of 35%. For the retrospective analysis of attendance with respiratory complaints 169 sets of notes were analysed, stratified for the results of bronchial provocation testing: group 1: 50 sets of notes for patients with a PC20FEV, of up to 2 mg/ml (bronchial hyperresponsiveness); group 2: 51 sets of notes for patients with a PC20FEV, above 2 and up to 32 mg/ml ("intermediate" bronchial responsiveness); group 3: 68 sets of notes for patients with a PC20FEV, above 32 mg/ml (control group).
Notes were selected so far as possible on a 1 in 3 basis from the random list of patients studied, to avoid bias; but because more women had bronchial responsiveness we had to add men to groups 2 and 3 to maintain a constant sex ratio across the groups.
STATISTICAL ANALYSIS
The results were analysed with the x2 test for the differences between proportions, Spear Methacholine challenge was carried out on 318 subjects. It was not performed in 48 subjects because of poor lung function (n = 11), ischaemic heart disease (n = 6), other cardiac disease (n = 2), pregnancy (n = 3), poor cooperation (n = 2), and refusal (n = 24).
Examination of case records showed that the prevalence of diagnosed hay fever or rhinitis and ofasthma was slightly higher in the responders (28/366 and 12/366) than in the nonresponders (21/647 and 11/647). This was significant for hay fever and rhinitis (7-6%: 3 2%, p < 0 05) but not for asthma (3-3%:1 7%).
RESPONSES TO THE QUESTIONNAIRE
A positive response was obtained from 32 subjects to the question "Have you at any time suffered from asthma?" (12 with symptoms in the last year), from 81 subjects to the question "Have you at any time suffered from attacks of wheezing of the chest?" from 196 people to the question "Have you at any time had attacks of coughing?" (though only 20 of these subjects said that they had regular attacks of coughing) and from 105 people to the question "Have you patients, and for at any time suffered from attacks of shortness of breath?" (only 15 of whom said that their attacks were regular). Ten people said that they woke at night with attacks of dyspnoea and 10 woke at night with attacks of wheeze. Ninety seven subjects answered "yes" to the question "Have you ever suffered from rhinitis or hay fever?" (20 of whom had had such an attack within the past month). There were 161 (44 5%) lifelong non-smokers, 105 (29%) current smokers, and 96 (26-5%) ex-smokers (that is, they had not smoked any tobacco for at least one month). Fifty one per cent of women and 37% of men had never smoked.
METHACHOLINE PC20FEV, VALUES
Bronchial hyperresponsiveness (PC20FEV, < 2 mg/ml) was present in 74 subjects (23% of those tested). A 20% fall in FEV, was seen in 172 subjects (fig 1) .
SKINPRICK TESTING
A response to at least one of the common allergens used was seen in 125 people (39%), who were therefore regarded as atopic.
RELATION BETWEEN SYMPTOMS, PC20FEV1, SEX, AGE, ATOPY, SMOKING, LUNG FUNCTION, AND CUTANEOUS HISTAMINE RESPONSE
Differences in the prevalence of bronchial hyperresponsiveness with age were not statistically significant (fig 2) .
Bronchial hyperresponsiveness was more common in women (31 %) than in men (13%; p < 0 001). Positive responses to the question "Have you ever suffered from attacks of wheezing of the chest?" were, however, almost evenly distributed between the sexes (31 % of women and 27% of men). Atopy was slightly more common in men (43%) than in women (35%).
Bronchial hyperresponsiveness was more common in atopic individuals (30 5%) than non-atopic individuals (17%; p < 0-01-see table 2 ). There was a positive relation between the presence of bronchial hyperresponsiveness and the number of positive skin test responses (r = 0-78, p = < 0 05-see fig 3) .
There was a weak but highly significant correlation between PC20FEV, and baseline FEV, (r = 0-266, p < 0-001) and a negative correlation between PC20FEV1 and mean daily peak flow variability (r = -0-241, p < 0-001).
Bronchial hyperresponsiveness was more common in subjects who had experienced at least one attack of wheeze (38%) than in subjects who had never had wheeze (18%; p < 0-001), but was no more common in subjects who had had attacks of cough or dyspnoea than in those who had not (23% v 24%). Bronchial hyperresponsiveness was more common in subjects who had had an attack of rhinitis within the last month (table 2) and was present in 48% of subjects who had ever had an attack of asthma and 73% of subjects who had had an attack ofasthma within the last year (table 2) . It was present in 18% of non-smokers, 21% of ex-smokers, and 32% of current smokers (p < 0-05; table 2).
Stepwise binary logistic regression analysis of independent predictor variables on bronchial hyperresponsiveness showed significant and independent predictive effects for mean daily peak flow variability, sex, the number of positive skinprick test responses, baseline FEVI, and histamine weal area (table 3) . There was no significant independent effect for mean allergen weal diameter or for smoking.
RETROSPECTIVE ANALYSIS OF ATTENDANCE WITH RESPIRATORY COMPLAINTS
There was no significant difference in numbers of attendances for upper or lower respiratory complaints between the three groups of patients (fig 4) . The subjects' characteristics are shown in table 4 . The ratio of women to 
Discussion
In this study of a systematic 1:12 sami general practice population we aimed to a representative sample of the local pop to determine the prevalence and associal bronchial hyperresponsiveness. Severa community studies have been publishe this study started.'01' 20-23 Our study di the technique of recruitment, the availat information on non-responders, and the study. The sample shows some bias t recruitment of individuals from the 40-A age group, who tend to volunteer frequently for studies" 24 (table 1) . replacements for non-responders has imised but not eliminated this bias beca could not obtain matched replacemei non-responders from the three lists in all cases-for 49/415 of the initial sample (12%) no replacement was found. The ratio of men to women (about 3:4), however, reflects that in the practice (2650:3274 in 1984). Study of case records on non-responders confirmed the tendency for symptomatic individuals to attend for tests. The prevalence of current asthma, however, was similar to that in the practice. During 1984, all attenders at the surgery (85% of the practice population attend for some complaint at least once a year) were asked if they had symptoms of asthma in the preceding year as part of a continuous survey27 and the prevalence of current asthma was 4 9% in the age range 18-75, compared with about 4-6% (17/371) in the volunteers (including the five with severe asthma). Although the prevalence among non-responders was lower, the non-responders included multiple Of the 74 subjects with bronchial hyperresponsiveness, 63 did not admit to having current asthma. There was a strong association between bronchial hyperresponsiveness and the symptom of wheezing, though 33 subjects had never wheezed. Symptoms of cough and dyspnoea were not associated with bronchial hyperresponsiveness and this was not a function of sample size (fig 3) . This may be because cough and dyspnoea are less closely associated with airway narrowing. Dyspnoea, however, has been shown to be a predictor for bronchial hyperresponsiveness when the sample is weighted towards a high proportion of symptomatic individuals. 24 Of those with rhinitis in the preceding month, 45% had bronchial hyperresponsiveness but only 20 individuals were affected and the association did not reach significance. Allergen exposure is known to increase bronchial responsiveness in sensitised individuals4' and this may explain the greater prevalence of bronchial hyperresponsiveness among those with greater numbers of positive skin test responses.
As in other studies, bronchial hyperresponsiveness was more prevalent in smokers and individuals with a low FEV,.'01' Smoking was not a significant independent predictor for bronchial hyperresponsiveness when stepwise binary logistic regression was carried out, which suggests that the interrelation with low FEV, was a stronger influence. Because of the relatively few individuals in the older age groups we could not look for the interaction of smoking and age with bronchial responsiveness found by Burney and coworkers. " Peak flow variability was correlated with bronchial responsiveness despite the small numbers with known asthma. The association was independent of other factors. Peak flow variability appeared to have a continuous distribution similar to that of bronchial hyperresponsiveness, and the degree of variability seen in asthma4' is one end of the spectrum.
In summary, the prevalence of bronchial hyperresponsiveness far exceeded that of asthma in this general practice population sample. The phenomenon appeared to be multifactorial in origin with independently significant associations with mean daily peak flow variability, female gender, atopy, resting FEV,, and histamine weal area. Despite the associations with asthma and wheezing, some individuals with bronchial hyperresponsiveness were apparently asymptomatic, and overall attendance at the surgery with respiratory complaints was not significantly increased.
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